Salidroside Boosts Stem Cell Therapy to Reverse Premature Ovarian Failure
Combining the Rhodiola compound salidroside with mesenchymal stem cells restores ovarian function by blocking iron-driven cell death in a rat model.
4,593 articles in this topic
Combining the Rhodiola compound salidroside with mesenchymal stem cells restores ovarian function by blocking iron-driven cell death in a rat model.
A new study reveals Piezo1 mechanosensitive channels decode time-dependent matrix mechanics, expanding understanding of how cells read their environment.
Pregnancy triggers sweeping respiratory changes driven by hormones and mechanics. Here's what clinicians need to know.
A landmark study identifies aged cytotoxic T cells and their secreted factor Granzyme K as key drivers of cognitive decline — and shows removing them restores memory.
A landmark review maps 272 genes tied to primary ovarian insufficiency, clarifying chromosomal and monogenic causes affecting 3.7% of women under 40.
A UK Biobank study of 215,695 adults shows combining genetic, lipid, and inflammatory markers improves CAD risk prediction by 32% over standard tools.
A cross-industry white paper establishes best practices for LIVCA, a critical quality control benchmark ensuring biologic drugs remain consistent and safe.
Moderna's mRNA-1010 influenza vaccine cut flu illness by 26.6% more than standard-dose vaccines in a 40,000-person phase 3 trial.
A mechanistic deep dive into UPR signaling architecture, crosstalk, and cutting-edge therapeutic strategies — from branch-selective inhibitors to proteostasis network engineering for longevity.
The CDK4/6 inhibitor palbociclib cuts disease progression risk by 24% in HR+/HER2+ metastatic breast cancer, extending survival by over a year.
Midterm TAVR data reveal a stark gap: trials show 73%+ valve survival, but real-world registries show 45%+ mortality by 7 years.
New population models show asymptomatic ALS gene carriers will nearly triple by 2035, straining specialized clinic capacity nationwide.